Core Viewpoint - The article provides an overview of recent IPO activities across Hong Kong, the US, and A-shares, highlighting several companies preparing for their public listings and their respective market positions. Group 1: Muxi Integrated Circuit - Muxi Integrated Circuit (Shanghai) Co., Ltd. officially listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 17, 2025, with the stock code "688802" [3] - Founded in 2020, Muxi is a leading domestic high-performance general-purpose GPU product company, focusing on the research, design, and sales of GPUs for AI training, inference, general computing, and graphics rendering [3] - Muxi's GPU products have achieved cumulative sales of over 25,000 units by the end of March 2025, with a revenue compound growth rate of 4074.52% over the past three years, and revenue of 915 million yuan in the first half of this year [5] Group 2: Woan Robotics - Woan Robotics (Shenzhen) Co., Ltd. plans to officially list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "6600" [7] - The company aims to become the "first stock of AI-embodied household robots," with an IPO market valuation between 14 billion and 18 billion HKD, raising up to 1.8 billion HKD [8] - Woan Robotics is recognized as the only company globally to comprehensively layout AI-embodied household robot systems, holding an 11.9% market share in the sector by 2024 [10] Group 3: Xunce Technology - Xunce Technology plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "3317," marking it as the first company in China's AI data sector to complete an IPO [12] - The company aims to raise up to 1.2375 billion HKD through its IPO, with a focus on real-time data infrastructure and analysis solutions [12] - Xunce Technology's real-time data solutions are noted for their speed and consistency, optimizing business efficiency and flexibility [14] Group 4: InSilico Medicine - InSilico Medicine plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "3696," aiming to raise up to 2.3 billion HKD [16] - The company is recognized as the largest biotech IPO in Hong Kong this year, with a focus on AI-driven drug development across various industries [17] - InSilico's core asset, Rentosertib, is a first-in-class candidate drug for idiopathic pulmonary fibrosis, showcasing the company's innovative capabilities [18] Group 5: Linqingxuan - Linqingxuan Cosmetics Group plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "2657," aiming to raise over 1 billion HKD [21] - The company is positioned as the leading high-end domestic skincare brand in China, with a complete product matrix in anti-wrinkle and firming skincare [22] - Linqingxuan ranks first among all domestic high-end skincare brands in China by retail revenue in 2024 [22] Group 6: 51WORLD - 51WORLD plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "6651," aiming to become the "first stock of Physical AI" [24] - The company has established a comprehensive technology capability in Physical AI, with products applied in various industries globally [24] - 51WORLD's revenue has shown significant growth, with a 63.6% increase in the first half of this year compared to the same period last year [26] Group 7: Qingsong Health Group - Qingsong Health Group plans to list on the Hong Kong Stock Exchange on December 23, 2025, with the stock code "2661," aiming to raise over 600 million HKD [28] - The company operates as a one-stop digital health and insurance service platform, covering various health-related services [28] - Qingsong Health Group's revenue has grown significantly, with an 84.7% increase in the first half of this year compared to the previous year [29] Group 8: Biran Technology - Biran Technology has passed the hearing for its listing on the Hong Kong Stock Exchange, focusing on general intelligent computing solutions [31] - The company has shown strong growth potential, with significant sales agreements in place and a focus on AI data centers and telecommunications [32] Group 9: Zhipu Technology - Zhipu Technology has passed the hearing for its listing on the Hong Kong Stock Exchange, aiming to become the "first stock of global large models" [35] - The company has achieved significant revenue growth, with a compound annual growth rate of 130% from 2022 to 2024 [36] Group 10: Tiandu Intelligent Chip - Tiandu Intelligent Chip has passed the hearing for its listing on the Hong Kong Stock Exchange, focusing on general-purpose GPU chips [38] - The company has seen a significant increase in customer numbers and product shipments, reflecting strong market recognition [39]

瑞财经 严明会 12月14日，上海林清轩生物科技股份有限公司（以下简称：林清轩）通过聆讯，其本月2日刚刚递交 更新后的IPO招股书，联席保荐人为中信证券和华泰国际。 最新数据显示，截至2025年6月30日，林清轩在全国有554家门店，其中超过95%的门店位于购物商场。根据灼识谘 询的资料，按门店总数计，于中国的国货及国际高端护肤品牌中排名第一。 2025年上半年，林清轩收入增93%至10.52亿元，净利润增120%至1.82亿元，毛利率超82%。 | | | 截至12月31日止年度 | | 截至6月30日止六個月 | | | --- | --- | --- | --- | --- | --- | | | 2022年 | 2023年 | 2024年 | 2024年 | 2025年 | | | | | (人民幣千元) | | | | | | | | (未經審核) | | | 仅人 | 691.150 | 805.004 | 1,209,641 | 530.448 | 1.051.768 | | 销售成本 | (152,073) | (151,141) | (211.985) | (96.115) | (185.5 ...

近日，知名国货美妆品牌林清轩重新提交了IPO申请文件。 据悉，该品牌最早于今年5月启动上市流程，彼时以上海林清轩生物科技股份有限公司为主体，向港交 所递交招股书，计划登陆主板市场。 林清轩业绩爆发式增长，离不开公司线上业务的快速增长。据招股书资料，通过IP矩阵、内部直播间、 与KOL和KOC合作以及各大电商平台官方品牌店举办的直播，公司的在线销售持续快速增长，从而成 为推动公司业务表现的关键驱动因素。 股权运作上，据招股书披露，上市前创始人孙来春直接持有38.21%的股份，为第一大股东，另通过3家 公司间接持股，合计持有林清轩公司约79.27%股份。 公司外部投资者包括雅戈尔时尚、碧桂园创投、头头是道基金、远隆发展等。其中，雅戈尔时尚持股 4.49%；碧桂园创投通过佛山海禹嘉和佛山汇碧二号分别持股2.69%和1.26%；头头是道基金持股 3.59%；远隆发展持股0.9%。 融资历程方面，2021年1月，林清轩完成A轮数亿元融资，投资方包括海纳华上海、头头是道基金、碧 桂园创投旗下的佛山海禹嘉、达隆发展、混沌创新、上海涛敏等机构。 而在此次更新的招股书中，公司名称发生正式变更，由原先的"上海林清轩生物科技股份有 ...

Investment Rating - The report maintains a "Positive" investment rating for the industry [1] Core Insights - The report highlights the growth in tourism between China and Cambodia, driven by the new visa-free policy, which is expected to boost tourist flows [5][15] - The breakfast market in China is identified as a significant opportunity, with major brands like Mixue and Guoming entering the segment [6][33] - The education sector is experiencing a shift towards vocational training due to declining numbers in traditional higher education applications, emphasizing employment-oriented education [39][44] - Lin Qingxuan, a high-end domestic skincare brand, is showing strong growth in both online and offline sales, with a notable increase in revenue and profit margins [45][50] Summary by Sections 1. Travel and Tourism - Cambodia has implemented a visa-free policy for Chinese citizens, expected to increase tourist numbers significantly, with a 45% year-on-year increase in Chinese tourists from January to October 2025 [5][15] - In November 2025, Hainan's duty-free shopping reached 2.38 billion yuan, a 27.1% increase year-on-year, despite a slight decrease in shopping visitors [23][24] 2. Breakfast Market - The breakfast market in China is valued at approximately 1.7 trillion yuan, with the external breakfast market estimated between 700 to 800 billion yuan [6][33] - Mixue has launched breakfast offerings in several cities, targeting consumers with affordable pricing [37][38] 3. Education Sector - The number of students taking the national college entrance examination has decreased for the first time in eight years, with a significant drop in graduate school applications [39][40] - Vocational education is gaining traction as students seek better employment outcomes, with a reported 95%+ employment rate in vocational programs [44] 4. Skincare Industry - Lin Qingxuan reported a revenue of 1.05 billion yuan in the first half of 2025, marking a 98.3% year-on-year increase, with online sales growing significantly [45][47] - The brand's product mix includes a high proportion of premium skincare items, contributing to improved profit margins [50][55] 5. Market Performance - The Hong Kong stock market saw the consumer services and media sectors underperforming, while the retail sector outperformed the market [59][65] - Notable stock performances included significant gains in retail and education sectors, with specific companies like Liufu Group and Gaoxin Retail leading the gains [65][66]

近日，国货美妆品牌林清轩已重新递交并更新了IPO申请文件。据悉，今年5月，林清轩首次向港交所 递交招股书开启上市之路。 最新递交的招股书主要更新了2025年上半年的业绩，上半年林清轩总营收为10.5亿元，同比2024年上半 年同比增长高达98%。 同时，林清轩已将公司名称由"上海林清轩生物科技有限公司"更名为"上海林清轩化妆品集团有限公 司"。公司在文件中解释称，鉴于其定位为中国高端国货护肤品牌，已于2025年11月完成更名。 定位高端 林清轩成立于2003年，总部位于上海，由来自东北的孙来春、孙福春兄弟联合创立。当前聚焦抗皱紧致 类护肤品，其核心产品定价200—800元区间。 在招股书中，林清轩多次强调其高端定位，并引用说明道，根据灼识咨询的资料，于2024年，按零售额 计，林清轩在中国所有高端国货护肤品牌中排名第一，也是中国前15大高端护肤品牌中唯一的国货品 牌。 "我们营运所在的中国高端护肤品行业相对集中，根据灼识咨询的资料，前15大品牌占据了66.1%的市 场份额。"林清轩在招股书中也提及了竞争风险："可能面临来自现有竞争对手或新准入者在定价方面的 竞争，这可能导致价格下跌或利润率降低，从而对我们的盈 ...

记者丨陈归辞 编辑丨易佳颖 近日，国货美妆品牌林清轩已重新递交并更新了IPO申请文件。据悉，今年5月，林清轩首次向港交所递交招股书开启上市之路。 最新递交的招股书主要更新了2025年上半年的业绩， 上半年林清轩总营收为10.5亿元，同比2024年上半年同比增长高达98%。 林清轩 成立于2003年，总部位于上海，由来自东北的孙来春、孙福春兄弟联合创立。当前聚焦抗皱紧致类护肤品，其核心产品定价200—800 元区间。 在招股书中，林清轩多次强调其高端定位 ，并引用说明道，根据灼识咨询的资料，于2024年，按零售额计，林清轩在中国所有高端国货护肤品 牌中排名第一，也是中国前15大高端护肤品牌中唯一的国货品牌。 "我们营运所在的中国高端护肤品行业相对集中，根据灼识咨询的资料，前15大品牌占据了66.1%的市场份额。"林清轩在招股书中也提及了竞 争风险："可能面临来自现有竞争对手或新准入者在定价方面的竞争，这可能导致价格下跌或利润率降低，从而对我们的盈利能力造成不利影 响。" 这一定位具体到产品上，林清轩几乎是依靠单一精华油品类撑起总体业绩近四成收入。招股书显示，精华油贡献的营收在2025年上半年占到 45.5%，在 ...

（原标题：林清轩再度递表港交所，"国货高端护肤第一股"成色几何？） 21世纪经济报道记者 陈归辞 易佳颖 近日，国货美妆品牌林清轩已重新递交并更新了IPO申请文件。据悉，今年5月，林清轩首次向港交所 递交招股书开启上市之路。 最新递交的招股书主要更新了2025年上半年的业绩，上半年林清轩总营收为10.5亿元，同比2024年上半 年同比增长高达98%。同时，林清轩已将公司名称由"上海林清轩生物科技有限公司"更名为"上海林清 轩化妆品集团有限公司"。公司在文件中解释称，鉴于其定位为中国高端国货护肤品牌，已于2025年11 月完成更名。 定位高端 在招股书中，林清轩多次强调其高端定位，并引用说明道，根据灼识咨询的资料，于2024年，按零售额 计，林清轩在中国所有高端国货护肤品牌中排名第一，也是中国前15大高端护肤品牌中唯一的国货品 牌。 "我们营运所在的中国高端护肤品行业相对集中，根据灼识咨询的资料，前15大品牌占据了66.1%的市 场份额。"林清轩在招股书中也提及了竞争风险："可能面临来自现有竞争对手或新准入者在定价方面的 竞争，这可能导致价格下跌或利润率降低，从而对我们的盈利能力造成不利影响。" 这一定位具体到 ...

还是中国女人的钱好挣啊！ 这不，"贵妇级护肤品"，又又递交招股书了！ 没错，此前招股书失效后，林清轩立马重新递表，更新了很多内容。 甚至，连公司名字都改了！ 招股书显示，林清轩将此前的"生物科技"字眼，换成了"化妆品集团"。 除了名字变更外，林清轩还更新了财报数据。 好家伙，这"卖面油"的公司，简直比"卖石油"还赚钱。 毛利率更是高得离谱，超过一众白酒企业。 | | | | 截至12月31日止年度 | | | | | 截至6月30日止六個月 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 2022年 | | 2023年 | | 2024年 | | 2024年 | | 2025年 | | | | | 毛利率 | | 毛利率 | | 毛利率 | | 毛利率 | | 毛利率 | | | 毛利 | (%) | 毛利 | (%) | 毛利 | (%) | 毛利 | (%) | 毛利 | (%) | | | | | | | (人民幣千元,百分比除外) | | | | | | | | | | | | | | (未經審 ...

Core Viewpoint - The China Securities Regulatory Commission has confirmed the overseas listing applications for several companies, including Dongpeng Beverage, Saintong Medical, Youlesai, Linqingxuan, Jinxun Co., Muyuan Foods, Basic Semiconductor, Huasheng Technology, Xiantong International, and Wuyi Vision, with Huasheng Technology applying for a listing in Taiwan and the others in Hong Kong [1]. Group 1: Dongpeng Beverage - Dongpeng Beverage plans to issue no more than 66,446,000 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company focuses on beverage R&D, production, and sales, particularly in the functional beverage sector, with products including energy drinks, sports drinks, tea, coffee, plant protein drinks, and fruit and vegetable juices [3]. - Financial projections for Dongpeng Beverage show revenues of 8.5 billion, 11.257 billion, 15.83 billion, and 10.732 billion for 2022 to 2025, with corresponding net profits of 1.441 billion, 2.04 billion, 3.326 billion, and 2.375 billion [3]. Group 2: Saintong Medical - Saintong Medical intends to issue no more than 12,298,300 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company specializes in the R&D, production, and sales of special medical purpose formula foods, particularly in the infant medical food sector [5]. - Financial forecasts for Saintong Medical indicate revenues of 491 million, 654 million, and 834 million for 2022 to 2024, with net profits of 83.89 million, 170 million, and 91.14 million [5]. Group 3: Youlesai - Youlesai plans to issue no more than 26,833,500 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is a leading integrated circular packaging service provider for the automotive industry, offering solutions and smart logistics systems [8]. - Financial projections for Youlesai show revenues of 648 million, 794 million, and 838 million for 2022 to 2024, with net profits of 3.12 million, 64.15 million, and 50.74 million [8]. Group 4: Linqingxuan - Linqingxuan intends to issue no more than 16,061,400 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is a high-end skincare brand focusing on plant-based skincare products, using camellia oil as a core ingredient [10]. - Financial forecasts for Linqingxuan indicate revenues of 691 million, 805 million, and 1.21 billion for 2022 to 2024, with net profits of -5.93 million, 84.52 million, and 187 million [10]. Group 5: Jinxun Co. - Jinxun Co. plans to issue no more than 42,280,400 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is involved in the development, smelting, and processing of non-ferrous metal new energy materials, with core businesses including cathode copper production and cobalt product processing [11]. - Financial projections for Jinxun Co. show revenues of 637 million, 676 million, and 1.77 billion for 2022 to 2024, with net profits of 84 million, 29 million, and 202 million [11]. Group 6: Muyuan Foods - Muyuan Foods intends to issue no more than 546,276,700 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company operates a full industry chain in pig farming, including feed processing, breeding, and meat processing [12]. - Financial forecasts for Muyuan Foods indicate revenues of 124.8 billion, 110.9 billion, and 138 billion for 2022 to 2024, with net profits of 14.933 billion, -4.168 billion, and 18.925 billion [12]. Group 7: Basic Semiconductor - Basic Semiconductor plans to issue no more than 39,357,800 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company focuses on the R&D and industrialization of silicon carbide power devices, with products used in photovoltaic storage and industrial control [15]. - Financial projections for Basic Semiconductor show revenues of 117 million, 221 million, and 299 million for 2022 to 2024, with net losses of 242 million, 342 million, and 237 million [15]. Group 8: Huasheng Technology - Huasheng Technology intends to issue no more than 9,100,000 ordinary shares and list on the Taiwan Stock Exchange [1]. - The company specializes in manufacturing electronic connectors and related products, including automotive wiring harnesses and RF antennas [17]. Group 9: Xiantong International - Xiantong International plans to issue no more than 9,259,900 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is a comprehensive enterprise focusing on pharmaceutical R&D, production, and sales, with a pipeline targeting oncology and neurodegenerative diseases [19]. - Financial forecasts for Xiantong International indicate revenues of 10.23 million and 44.06 million for 2022 to 2024, with net losses of 309 million and 156 million [19]. Group 10: Wuyi Vision - Wuyi Vision intends to issue no more than 77,600,840 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company focuses on digital twin technology, providing applications for smart cities and industrial simulation [21]. - Financial projections for Wuyi Vision show revenues of 170 million, 256 million, and 287 million for 2022 to 2024, with net losses of 190 million, 87 million, and 82 million [21].

Core Insights - L'Oréal has announced an investment in the Chinese skincare brand "LAN" through its subsidiary Shanghai Meici Fang Investment Co., supported by the BOLD strategic innovation fund, marking its first investment in a local skincare brand [1][11] - LAN, founded in 2019, focuses on "oil-based skincare" and "biotechnology plant extracts," with a product lineup that includes series like Time Orchid and Phoenix Whitening [1][5] - The brand has maintained a conservative approach in product launches, with nearly 20 SKUs over six years, emphasizing research and user experience rather than rapid expansion [3][5] Investment Details - The investment is significant as it represents L'Oréal's shift towards local brands with strong technical barriers and user loyalty, rather than just large-scale potential brands [11] - Prior to this, L'Oréal's investments in China were primarily in fragrance and supply chain projects, indicating a strategic pivot towards the skincare sector [11] Market Position - LAN has been ranked first in sales within the domestic facial oil category for two consecutive years, according to a report by Sullivan [1][5] - The brand's pricing strategy positions its products in the 200 to 300 RMB range, slightly lower than competitors like Lin Qingxuan, which has seen significant promotional activity affecting price overlap [6][10] Consumer Feedback and Challenges - Consumer feedback on LAN's products shows a divide, with some users finding the texture slightly sticky while others appreciate the absorption after proper application [8][10] - The brand faces challenges in market education and expanding its consumer base, particularly in a market where oil-based skincare is still met with skepticism [10] Future Strategy - LAN plans to invest further in functional oil research and plant extract technology, enhance offline retail experiences, and optimize supply chains and production capacity [1][5] - The brand must navigate the growth ceiling in the facial oil market while maintaining its competitive edge and exploring stable product extension strategies [10][11]